Unibest
← Back to patent-cliff list

Dienogest/Estradiol Valerate

Tier C — Watch / trade

Dienogest/Estradiol Valerate

Bayer
Originator
2010
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:ERs, PR

Brand:Natazia

Indications (approved):Contraception

Regional status

US
Approved
2010-05-06
EU
No progress
2004-04-01
China
No progress
2014-04-29
Japan
-

Factories producing this API9

Factories registered as producing this API in our sourcing network (RFQ records + product master), sorted by RFQ activity; the snapshot carries no cost or customer data.

9 producing factories on file — sign in to view the named list (factory details are not shown to guests).

Sign in to view factories →

Synthetic routes & intermediates8 routes

Originator routes × 0Optimised (non-patent) × 8Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OptimisedRoute 1Steps 3 · Total yield 90g(Estradiol Valerate (Free))
Estradiol Valerate-001—Estradiol Valerate-002—Estradiol Valerate-00363042-28-4Estradiol Valerate-004—API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
Estradiol Valerate-001-(17beta)-Estra-1,3,5(10)-triene-3,17-diol
Estradiol Valerate-002-Pentanoic anhydride
Estradiol Valerate-00363042-28-4(17beta)-Estra-1,3,5(10)-triene-3,17-diyl dipentanoate
Estradiol Valerate-004-Butanecarboxylic acid
OptimisedRoute 1Steps 2 · Total yield /
(I)90248-1-a65928-65-6(II)90248-1-a—API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(I)90248-1-a65928-65-62-(17beta-Hydroxy-3-oxoestr-5(10)-en-17-yl)acetonitrile
(II)90248-1-a-2-[(10S,11S,14R,15S)-2,7-dibromo-14-hydroxy-15-methyl-5-oxotetracyclo[8.7.0.0(2,7).0(11,15)]heptadecan-14-yl]acetonitrile
OptimisedRoute 2Steps 4 · Total yield /
(I)90248-2-a17976-32-8(II)90248-2-a—(III)90248-2-a30925-89-4(IV)90248-2-a65928-64-5(V)90248-2-a—(VI)90248-2-a—(VII)90248-2-a—(VIII)90248-2-a75-05-8API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(I)90248-2-a17976-32-83-Methoxyestra-2,5(10)-dien-17-one
(II)90248-2-a-dimethyl(methylidene)-sulfane
(III)90248-2-a30925-89-4(1'S,2S,10'R,11'S,15'S)-5'-methoxy-15'-methylspiro[oxirane-2,14'-tetracyclo[8.7.0.0(2,7).0(11,15)]heptadecane]-2'(7'),4'-diene
(IV)90248-2-a65928-64-52-(17beta-Hydroxy-3-methoxyestra-2,5(10)-dien-17-yl)acetonitrile
(V)90248-2-a-2-[(1S,10R,11S,14R,15S)-14-hydroxy-15-methyl-5-oxotetracyclo[8.7.0.0(2,7).0(11,15)]heptadec-2(7)-en-14-yl]acetonitrile
(VI)90248-2-a-3,3-Dimethoxyestra-5,9-dien-17-one
(VII)90248-2-a-3-Ethoxyestra-3,5,9-trien-17-one
(VIII)90248-2-a75-05-8Acetonitrile anhydrous
OptimisedRoute 3Steps 4 · Total yield /
(I)90248-3-a5173-46-6(II)90248-3-a126-30-7(III)90248-3-a91175-92-7(IV)90248-3-a1253857-90-7(V)90248-3-a1253857-91-8API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(I)90248-3-a5173-46-6Estra-4,9-diene-3,17-dione
(II)90248-3-a126-30-71,3-Dihydroxy-2,2-dimethylpropane
(III)90248-3-a91175-92-73,3-(2,2-Dimethyl-1,3-propylenedioxy)estra-5(10),9(11)-dien-17-one
(IV)90248-3-a1253857-90-73,3-(2,2-Dimethyl-1,3-propylenedioxy)-17beta,17beta-(methyleneoxy)estra-5(10),9(11)-diene
(V)90248-3-a1253857-91-82-[3,3-(2,2-Dimethyl-1,3-propylenedioxy)-17beta-hydroxyestra-5(10),9(11)-dien-17-yl]acetonitrile
OptimisedRoute 4Steps 6 · Total yield /
(I)90248-4-a1624-62-0(II)90248-4-a133291-95-9(III)90248-4-a1255910-17-8(IV)90248-4-a17976-32-8(V)90248-4-a65928-64-5(VI)90248-4-a65928-65-6(VII)90248-4-a24284-84-2(VIII)90248-4-a110169-67-0API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(I)90248-4-a1624-62-03-Methoxyestra-1,3,5(10)-trien-17-one
(II)90248-4-a133291-95-93,17,17-Trimethoxyestra-1(10),2,4-triene
(III)90248-4-a1255910-17-83,17,17-Trimethoxyestra-2,5(10)-diene
(IV)90248-4-a17976-32-83-Methoxyestra-2,5(10)-dien-17-one
(V)90248-4-a65928-64-52-(17beta-Hydroxy-3-methoxyestra-2,5(10)-dien-17-yl)acetonitrile
(VI)90248-4-a65928-65-62-(17beta-Hydroxy-3-oxoestr-5(10)-en-17-yl)acetonitrile
(VII)90248-4-a24284-84-22-(17beta-Hydroxy-3-methoxyestra-1(10),2,4-trien-17-yl)acetonitrile
(VIII)90248-4-a110169-67-03-Methoxyestra-2,5(10)-dien-17-ol
OptimisedRoute 5Steps 2 · Total yield /
(I)90248-5-a10109-76-9(II)90248-5-a75-05-8(III)90248-5-a102193-41-9API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(I)90248-5-a10109-76-93,3-Dimethoxyestra-5(10),9(11)-dien-17-one
(II)90248-5-a75-05-8Acetonitrile anhydrous
(III)90248-5-a102193-41-917alpha-(Cyanomethyl)-3,3-dimethoxy-13beta-methylgonane-5(10),9(11)-dien-17beta-ol
OptimisedRoute 6Steps 2 · Total yield /
(III)90248-6-a190662-30-7(I)90248-6-a5571-36-8(II)90248-6-a75-05-8API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(III)90248-6-a190662-30-7[(8S,13S,14S,17R)-17-Hydroxy-13-methyl-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-yl]acetonitrile
(I)90248-6-a5571-36-817-Oxo-estradiene
(II)90248-6-a75-05-8Acetonitrile anhydrous
OptimisedRoute 7Steps 4 · Total yield /
(Ia)125457-3-a88128-57-8(Ib)125457-3-a88128-58-9(II)125457-3-a1700622-26-9(III)125457-3-a1700616-94-9(IV)125457-3-a88128-63-6(V)125457-3-a88128-61-4(VI)125457-3-a5173-46-6API · Dienogest/Estradiol Valerate
CodeCAS No.Intermediate
(Ia)125457-3-a88128-57-82-(3-Chloropropyl)-2,5,5-trimethyl-1,3-dioxane
(Ib)125457-3-a88128-58-92-(3-Bromopropyl)-2,5,5-trimethyl-1,3-dioxane
(II)125457-3-a1700622-26-9(6aS,9aS,9bS)-6a-Methyldecahydrocyclopenta[f]chromene-3,7-dione
(III)125457-3-a1700616-94-9(3aS,4S,7aS)-5-Hydroxy-7a-methyl-4-[3-oxo-6-(2,5,5-trimethyl-1,3-dioxan-2-yl)hexyl]octahydro-1H-inden-1-one
(IV)125457-3-a88128-63-6(3aS,4S,7aS)-7a-Methyl-4-[3-oxo-6-(2,5,5-trimethyl-1,3-dioxan-2-yl)hexyl]hexahydro-1H-indene-1,5(4H)-dione
(V)125457-3-a88128-61-4(3aS,9aS,9bS)-3a-Methyl-6-[2-(2,5,5-trimethyl-1,3-dioxan-2-yl)ethyl]-4,5,8,9,9a,9b-hexahydro-1H-cyclopenta[a]naphthalene-3,7(2H,3aH)-dione
(VI)125457-3-a5173-46-6Estra-4,9-diene-3,17-dione

Frequently asked questions

What are the approved indications of Dienogest/Estradiol Valerate?

Approved indications include: Contraception.

When does the Dienogest/Estradiol Valerate patent expire?

No public expiry year is available for Dienogest/Estradiol Valerate yet; this page updates once verified.

How many synthesis routes are recorded for Dienogest/Estradiol Valerate?

8 synthesis routes are recorded; the shortest is 2 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Dienogest/Estradiol Valerate intermediates?

All intermediates in Dienogest/Estradiol Valerate routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Dienogest/Estradiol Valerate intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-09-29